Position in GILD
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$411,994
-$45,557 QoQ
Shares Held
3,261
-0.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,472
of 2,266 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Valmark Advisers, Inc. holds $25,445,603 across 11 Drug Manufacturers - General names. GILD ranks #8 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,846 | $7,011,868 | |
| 2 | JNJ |
Johnson & Johnson
|
23,608 | $5,995,723 | |
| 3 | MRK |
Merck & Co., Inc.
|
26,899 | $3,456,521 | |
| 4 | AMGN |
Amgen Inc
|
8,535 | $3,090,694 | |
| 5 | ABBV |
AbbVie Inc.
|
10,340 | $2,601,957 | |
| 6 | NVS |
Novartis AG
|
8,050 | $1,261,596 | |
| 7 | PFE |
Pfizer Inc
|
33,525 | $807,282 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
3,261 | $411,994 |
All Filings in GILD
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $411,994 | 3,261 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $457,551 | 3,283 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $386,999 | 3,153 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $352,092 | 3,172 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $375,294 | 3,385 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $379,401 | 3,386 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $322,463 | 3,491 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $298,051 | 3,555 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $286,309 | 4,173 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $277,544 | 3,789 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $343,158 | 4,236 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $371,852 | 4,962 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $388,509 | 5,041 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $411,448 | 4,959 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $417,316 | 4,861 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $261,750 | 4,243 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $263,805 | 4,268 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $254,743 | 4,285 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $334,078 | 4,601 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $369,855 | 5,295 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $376,388 | 5,466 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $352,685 | 5,457 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $238,341 | 4,091 | Shares | Sole | 2021-02-03 | |
| No filing history on record for this holder in this stock. | ||||||